These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 32432400

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. The erythrocyte alloimmunisation in patients with sickle cell anaemia: a systematic review.
    da Cunha Gomes EG, Machado LAF, de Oliveira LC, Neto JFN.
    Transfus Med; 2019 Jun; 29(3):149-161. PubMed ID: 29845661
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
    Talano JA, Hillery CA, Gottschall JL, Baylerian DM, Scott JP.
    Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
    [Abstract] [Full Text] [Related]

  • 46. The role of molecular typing and perfect match transfusion in sickle cell disease and thalassaemia: An innovative transfusion strategy.
    Putzulu R, Piccirillo N, Orlando N, Massini G, Maresca M, Scavone F, Ricerca BM, Zini G.
    Transfus Apher Sci; 2017 Apr; 56(2):234-237. PubMed ID: 28185828
    [Abstract] [Full Text] [Related]

  • 47. Genomic analyses of RH alleles to improve transfusion therapy in patients with sickle cell disease.
    Reid ME, Halter Hipsky C, Hue-Roye K, Hoppe C.
    Blood Cells Mol Dis; 2014 Apr; 52(4):195-202. PubMed ID: 24309423
    [Abstract] [Full Text] [Related]

  • 48. DNA-based typing of blood groups for the management of multiply-transfused sickle cell disease patients.
    Castilho L, Rios M, Bianco C, Pellegrino J, Alberto FL, Saad ST, Costa FF.
    Transfusion; 2002 Feb; 42(2):232-8. PubMed ID: 11896340
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. RH genotype matching for transfusion support in sickle cell disease.
    Chou ST, Evans P, Vege S, Coleman SL, Friedman DF, Keller M, Westhoff CM.
    Blood; 2018 Sep 13; 132(11):1198-1207. PubMed ID: 30026182
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. DNA array analysis for red blood cell antigens facilitates the transfusion support with antigen-matched blood in patients with sickle cell disease.
    Ribeiro KR, Guarnieri MH, da Costa DC, Costa FF, Pellegrino J, Castilho L.
    Vox Sang; 2009 Aug 13; 97(2):147-52. PubMed ID: 19392786
    [Abstract] [Full Text] [Related]

  • 58. When and why is red blood cell genotyping applicable in transfusion medicine: a systematic review of the literature.
    Akinbolaji TJ.
    Immunohematology; 2024 Jun 01; 40(2):58-64. PubMed ID: 38910442
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. The experience of extended blood group genotyping by next-generation sequencing (NGS): investigation of patients with sickle-cell disease.
    Fichou Y, Mariez M, Le Maréchal C, Férec C.
    Vox Sang; 2016 Nov 01; 111(4):418-424. PubMed ID: 27442304
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.